Cargando…

The relationship between cisplatin resistance and histone deacetylase isoform overexpression in epithelial ovarian cancer cell lines

OBJECTIVE: To investigate the relationship between cisplatin resistance and histone deacetylase (HDAC) isoform overexpression in ovarian cancer cell lines. METHODS: Expression of four HDAC isoforms (HDAC 1, 2, 3, and 4) in two ovarian cancer cell lines, SKOV3 and OVCAR3, exposed to various concentra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Min-Gyun, Pak, Jhang Ho, Choi, Won Ho, Park, Jeong-Yeol, Nam, Joo-Hyun, Kim, Jong-Hyeok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Gynecologic Oncology and Colposcopy 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395014/ https://www.ncbi.nlm.nih.gov/pubmed/22808361 http://dx.doi.org/10.3802/jgo.2012.23.3.182

Ejemplares similares

Histone Deacetylase Inhibitor Therapy in Epithelial Ovarian Cancer
por: Takai, Noriyuki, et al.
Publicado: (2010)

Histone Deacetylases and Their Isoform-Specific Inhibitors in Ischemic Stroke
por: Demyanenko, Svetlana, et al.
Publicado: (2021)

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
por: Pchejetski, Dmitri, et al.
Publicado: (2015)

Histone deacetylase inhibitor trichostatin A sensitises cisplatin-resistant ovarian cancer cells to oncolytic adenovirus
por: Hulin-Curtis, Sarah L., et al.
Publicado: (2018)

Molecular Modeling Study on Tunnel Behavior in Different Histone Deacetylase Isoforms
por: Thangapandian, Sundarapandian, et al.
Publicado: (2012)

Effect of 3-subsitution of quinolinehydroxamic acids on selectivity of histone deacetylase isoforms
por: Mehndiratta, Samir, et al.
Publicado: (2020)

Effects of histone deacetylase inhibitor trichostatin A combined with cisplatin on apoptosis of A549 cell line
por: Zhang, Xuan, et al.
Publicado: (2015)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Histone deacetylase mediated silencing of AMWAP expression contributes to cisplatin nephrotoxicity
por: Ranganathan, Punithavathi, et al.
Publicado: (2016)

Expression Profile of Histone Deacetylase 1 in Gastric Cancer Tissues
por: Choi, Jae‐Hoon, et al.
Publicado: (2001)

Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer
por: Kim, Myung Joo, et al.
Publicado: (2012)

Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms
por: Weeks, Kate L, et al.
Publicado: (2015)

Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem Cells
por: Lin, Peng-Chan, et al.
Publicado: (2018)

Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis
por: Kim, Hyung Seok, et al.
Publicado: (2015)

Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
por: Guo, Fengyi, et al.
Publicado: (2022)

The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis
por: Xu, Long, et al.
Publicado: (2023)

Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines
por: Bandolik, Jan J., et al.
Publicado: (2019)

Protective Effects of Glucose-Related Protein 78 and 94 on Cisplatin-Mediated Ototoxicity
por: Yi, Junyeong, et al.
Publicado: (2020)

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
por: Zhang, P, et al.
Publicado: (2014)

Dual Inhibitors Against Topoisomerases and Histone Deacetylases
por: Seo, Young Ho
Publicado: (2015)

Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression
por: Wang, Jie, et al.
Publicado: (2021)

Isotype-Specific Inhibition of Histone Deacetylases: Identification of Optimal Targets for Radiosensitization
por: Kim, Jin Ho, et al.
Publicado: (2016)

Quantification of Histone Deacetylase Isoforms in Human Frontal Cortex, Human Retina, and Mouse Brain
por: Anderson, Kyle W., et al.
Publicado: (2015)

Isoform-specific characterization of class I histone deacetylases and their therapeutic modulation in pulmonary hypertension
por: Chelladurai, Prakash, et al.
Publicado: (2020)

Structural basis of the specific interaction of SMRT corepressor with histone deacetylase 4
por: Park, Suk-Youl, et al.
Publicado: (2018)

Association of histone deacetylase expression with histology and prognosis of ovarian cancer
por: Yano, Mitsutake, et al.
Publicado: (2018)

Hexamethylmelamine as Consolidation Treatment for Patients with Advanced Epithelial Ovarian Cancer in Complete Response after First-Line Chemotherapy
por: Kwon, Yong Soon, et al.
Publicado: (2009)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Carbocisteine Improves Histone Deacetylase 2 Deacetylation Activity via Regulating Sumoylation of Histone Deacetylase 2 in Human Tracheobronchial Epithelial Cells
por: Song, Yun, et al.
Publicado: (2019)

Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition
por: Flatmark, Kjersti, et al.
Publicado: (2006)

Sequence-Dependent Radiosensitization of Histone Deacetylase Inhibitors Trichostatin A and SK-7041
por: Kim, Jin Ho, et al.
Publicado: (2013)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Histone deacetylases and their roles in mineralized tissue regeneration
por: Huynh, Nam Cong-Nhat, et al.
Publicado: (2017)

Proteomic and transcriptomic profiles of human urothelial cancer cells with histone deacetylase 5 overexpression
por: Jaguva Vasudevan, Ananda Ayyappan, et al.
Publicado: (2022)

New histone deacetylase inhibitors improve cisplatin antitumor properties against thoracic cancer cells
por: Gueugnon, Fabien, et al.
Publicado: (2014)

The Impact of Fluorination on the Design of Histone Deacetylase Inhibitors
por: Tien Anh, Duong, et al.
Publicado: (2023)

Combination Effect of Silver Nanoparticles and Histone Deacetylases Inhibitor in Human Alveolar Basal Epithelial Cells
por: Gurunathan, Sangiliyandi, et al.
Publicado: (2018)

Combination of isoform-selective histone/protein deacetylase inhibitors improves Foxp3+ T-regulatory cell function
por: Beier, Ulf H., et al.
Publicado: (2012)

Histone Deacetylase Isoforms Differentially Modulate Inflammatory and Autoantibody Responses in a Mouse Model of Myasthenia Gravis
por: Bahauddin, Afrin, et al.
Publicado: (2022)

Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
por: Freese, Kim, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sp2nmhsg3lungr5gvr0i9l8pu4